When you give to The Hope Foundation, your donation goes directly to the frontlines of cancer research—fueling the work of the physicians, nurses, advocates, and scientists collaborating to improve treatments today.
90% of every dollar funds research — not overhead
We don’t fundraise for awareness campaigns or high administration costs.
Ninety cents of every dollar directly supports research and training through the SWOG Cancer Research Network—where 20,000+ oncology professionals are conducting clinical trials that shape the standard of care nationwide.
Led by the researchers who save lives
The Hope Foundation was founded by the doctors and scientists conducting the research itself. That means every dollar you give is used where it matters most—funding studies that directly improve patient outcomes.
When the people doing the work determine funding decisions, every contribution counts.
Advancing the latest care across the country – and beyond
Our network connects leading cancer centers and community clinics in 47 states and seven countries. That means a patient in rural Wyoming can access the same standard of care as someone at an academic hospital in Houston. Your support helps ensure that geography doesn’t determine one’s quality of care.
Donate NowWe fund science that others can’t – or won’t
Because we’re independent of for-profit interests, we can act quickly to fund promising new research that larger organizations might overlook. We prioritize patient-focused studies that make care more accessible, effective, and equitable.
Independent
We’re a 501(c)(3) advancing the work of publicly powered cancer clinical trials. We have a shared mission, not shareholders.
Nimble
Our staff collaborate directly with our researchers. This means we pursue the best science at the earliest opportunity. Cancer care is always changing, and we’re prepared to pivot when it matters most.
Patient-Focused
Our study teams treat patients. What they learn from the laboratory can directly inform care in the clinic. And this learning flows both ways: patients play a direct role in their care and help to improve care for others, too.
Stephen Bartlett, RPh, MSPH
Chair, SWOG Veterans Affairs Committee
Paul Gater
Patient Advocate for Myeloma
Paul Hesketh, MD
Chair, SWOG Professional Review Committee
Real breakthroughs. Lives improved.
Your gift fuels studies that have redefined how cancer is treated worldwide—research that’s saved millions of years of life and given new hope to countless families.
Together, we’re creating a future where better care reaches everyone who needs it.
100+
Changes in standards of care
14
Cancer drug approvals
2026
15-Year Results from SWOG’s S0016 Study Suggest Follicular Lymphoma Is Curable
A new long-term study challenges the belief that advanced follicular lymphoma is incurable, finding that about 42% of patients treated with standard therapy may be effectively cured and remain cancer-free for life.
2026
SWOG Cancer Research Network Celebrates 70 Years
SWOG Cancer Research Network marks its 70th year having enrolled nearly a quarter million participants to its clinical trials
2024
New Immunotherapy Combination Standard for Hodgkin Lymphoma
The SWOG S1826 trial established nivolumab plus AVD chemotherapy as the new standard of care for advanced Hodgkin lymphoma, replacing brentuximab vedotin + AVD with a regimen showing superior progression-free survival and fewer toxic side effects.
2024
Practice-Influential Trials Reach 82 and 14 Drug Approvals
By 2024, SWOG-led research had produced 82+ practice-influential trials and contributed to 14 FDA cancer drug approvals—representing over six decades of network-wide research that has fundamentally transformed how cancer is treated worldwide.
